HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

bapineuzumab

a nootropic agent; in clinical trials for treatment of Alzheimer's disease
Also Known As:
AAB 001; AAB-001
Networked: 59 relevant articles (3 outcomes, 37 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Brashear, H Robert: 19 articles (01/2019 - 03/2012)
2. Liu, Enchi: 12 articles (01/2018 - 04/2010)
3. Lu, Ming: 8 articles (01/2019 - 02/2015)
4. Salloway, Stephen: 7 articles (01/2018 - 03/2012)
5. Sperling, Reisa: 7 articles (01/2018 - 03/2012)
6. Grundman, Michael: 7 articles (01/2016 - 04/2010)
7. Imbimbo, Bruno P: 7 articles (10/2014 - 11/2010)
8. Panza, Francesco: 7 articles (10/2014 - 11/2010)
9. Solfrizzi, Vincenzo: 7 articles (10/2014 - 11/2010)
10. Fox, Nick C: 6 articles (01/2018 - 04/2010)

Related Diseases

1. Alzheimer Disease (Alzheimer's Disease)
2. Amyloid Plaque
3. Cognitive Dysfunction
4. Edema (Dropsy)
5. Dementia (Dementias)

Related Drugs and Biologics

1. solanezumab
2. Monoclonal Antibodies
3. Amyloid (Amyloid Fibrils)
4. Apolipoproteins E (ApoE)
5. Amyloid beta-Peptides
6. Biomarkers (Surrogate Marker)
7. gantenerumab
8. Humanized Monoclonal Antibodies
9. Amino Acids
10. Peptides (Polypeptides)

Related Therapies and Procedures

1. Immunotherapy
2. Therapeutics
3. Intravenous Injections